Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2022

  1. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

2019

  1. Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

    Translational Psychiatry, Vol. 9, Núm. 1

2009

  1. Cognitive performance and cigarette smoking in first-episode psychosis

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Núm. 2, pp. 65-71